A new brand called Elevant has launched an NMN supplement to support cellular health
Elevant, a brand of the Swiss biotech company Seneque, recently launched Prime capsules in the U.S. Prime is a clinically tested, high purity form of nicotinamide mononucleotide (NMN), a precursor of NAD+ (nicotinamide adenine dinucleotide).
Image courtesy of Elevant
Elevant (New York, NY), a brand of the Swiss biotech company Seneque, recently launched Prime capsules in the U.S. Prime is a clinically tested, high purity form of nicotinamide mononucleotide (NMN), a precursor of NAD+ (nicotinamide adenine dinucleotide). The high purity NMN, called NMN-C, is self-affirmed GRAS (generally recognized as safe) as of November 2020 after an independent panel of toxicology and nutrition experts rigorously evaluated research studies and toxicology data to conclude NMN-C was not harmful under its intended use: UL of 2.2 mg/lb for humans, or 300 mg for a 135-lb adult.
To further transparency, the results of a recent OECD 408 toxicology study on NMN-C were published. According to Elevant, this was a first of its kind study to be undertaken on NMN, analyzing the ingredient’s No Observable Adverse Effect Level (NOAEL). The company is also partnering with leading European and American institutions such as the Buck Institute for Research on Aging for preclinical research exploring the health benefits of NMN, and to propel further development of NMN-C to support cardiovascular, cognitive, muscular, skin, and immune health.
Prime is sold by Elevant directly to consumers and offers an annual subscription.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
